News
QIAGEN Partners With International Panel Physicians Association To Increase Awareness Of Tuberculosis Screening Requirements
18 Mar 24
Biotech, News, General
JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $52
8 Feb 24
News, Price Target, Analyst Ratings
Citigroup Maintains Buy on Qiagen, Lowers Price Target to $60
8 Feb 24
News, Price Target, Analyst Ratings
QIAGEN Sees FY24 EPS $2.10 CER Vs $2.20 CER Est.; Revenue Of At Least $2B CER Vs 2.06B CER Est.
6 Feb 24
News, Guidance
Qiagen Q4 EPS $0.55 Beats $0.53 Estimate, Sales $503.00M Beat $501.28M Estimate
6 Feb 24
Earnings, Earnings Beats, News
Earnings Scheduled For February 6, 2024
6 Feb 24
Earnings
Earnings Preview: Qiagen
5 Feb 24
Earnings
QIAGEN Announces Partnership With Penn State University To Advance Microbiome Sciences
25 Jan 24
Biotech, News, General
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
17 Jan 24
Analyst Color, News, Upgrades, Price Target, Analyst Ratings, Trading Ideas
QIAGEN Bags FDA Clearance of NeuMoDx CT/NG Assay for Both NeuMoDx 96 and 288 Molecular Systems
8 Jan 24
Government, News, Regulations, SEC
QIAGEN To Return ~$300M To Shareholders Through A Synthetic Share Repurchase
7 Jan 24
News, Buybacks
Qiagen's Health Odyssey: Expanding In Riyadh And Partnering In Public Projects
3 Jan 24
Equities, Mid Cap, News, Health Care, Markets, General
Press releases
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
25 Mar 24
Press Releases
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
18 Mar 24
Press Releases
QIAGEN announces Form 20-F annual report filing for 2023 results
11 Mar 24
Press Releases
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
27 Feb 24
Press Releases
QIAGEN announces partnership with Penn State University to advance microbiome sciences
25 Jan 24
Press Releases
QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million
18 Jan 24
Press Releases
QIAGEN N.V. to release results for Q4 2023 and hold webcast
11 Jan 24
Press Releases
QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems
8 Jan 24
Press Releases
QIAGEN announces plans to return approximately $300 million to shareholders
7 Jan 24
Press Releases
QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics business
4 Jan 24
Press Releases
QIAGEN expands business in Middle East with new regional headquarters and major projects
3 Jan 24
Press Releases